← Back to Clinical Trials
Recruiting NCT06576453

NCT06576453 Mixed-method Evaluation of a Parental Psychoeducation Programme in a Suicide Risk Prevention Group

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06576453
Status Recruiting
Phase
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Suicide Prevention
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-05-23
Primary Completion 2025-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Self-questionnaire WHOQOL-brefSelf-questionnaire Evaluation Inventory - Parentquiz of knowledge

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-05-23 with a primary completion date of 2025-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The number of emergency consultations for children and adolescents for suicidal ideation and suicide attempts has been rising steadily since 2010, and even more so since 2020. In addition, 30% of children and adolescents who have committed a suicidal act reoffend within the year. Psycho-education programmes for patients have been shown to be effective in a large number of psychiatric pathologies. The programs of psychoeducation for the caregivers of these patients have them also shown their effectiveness, however to date there is no parental psychoeducation program group, for the prevention of the suicidal risk of children and adolescents, which is validated. The service of child psychiatry at the Robert Debré hospital built a program for this purpose, according to current data from the science and has been offering it for 6 months to parents of patients who consulted for suicidal ideation. Rate this program through the description of its implementation would allow it to be validated, this in a dissemination objective. This validation through a mixed method would also allow us to describe the experience participants in this program and to understand improvements Track.

Eligibility Criteria

Inclusion Criteria: * Parent committing to participate in the 4 sessions of the parental psychoeducation prevention program suicide risk (PEPPS program) * Parents of children under 15 years and 6 months * Parents fluent in French Exclusion Criteria: * Lack of affiliation with a social security scheme or CMU (universal health coverage) * Parents under guardianship or curatorship

Contact & Investigator

Central Contact

Vincent TREBOSSEN, Dr

✉ vincent.trebossen@aphp.fr

📞 0140034146

Frequently Asked Questions

Who can join the NCT06576453 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06576453 currently recruiting?

Yes, NCT06576453 is actively recruiting participants. Contact the research team at vincent.trebossen@aphp.fr for enrollment information.

Where is the NCT06576453 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT06576453 clinical trial?

NCT06576453 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology